Recital 1, Decision_act (EU) 2023/1424

In forcesince 5 Jul 2023

Acrolein was included in Annex I to Directive 98/8/EC of the European Parliament and of the Council [Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market (OJ L 123, 24.4.1998, p. 1).] as an active substance for use in biocidal products of product-type 12. Pursuant to Article 86 of Regulation (EU) No 528/2012, it was therefore considered approved until 31 August 2020 under that Regulation subject to the requirements set out in Annex I to Directive 98/8/EC.